Page last updated: 2024-11-07

gbr 13119

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

GBR 13119: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131286
CHEMBL ID288914
SCHEMBL ID6254945
MeSH IDM0155714

Synonyms (13)

Synonym
76778-23-9
gbr 12966
gbr-12966
piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-(4-fluorophenyl)propyl)-
gbr 13119
CHEMBL288914 ,
1-(2-(diphenylmethoxy)ethyl)-4-(3-(4-fluorophenyl)propyl)piperazine
1-(2-benzhydryloxyethyl)-4-[3-(4-fluorophenyl)propyl]piperazine
DTXSID30227586
SCHEMBL6254945
AKOS030253249
bdbm50474041
Q15634066
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID64533Inhibition of [3H]dopamine uptake in HEK293 cells expressing recombinant Dopamine transporter2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
GBR compounds and mepyramines as cocaine abuse therapeutics: chemometric studies on selectivity using grid independent descriptors (GRIND).
AID64534Inhibition of radioligand [125I]RTI-55 binding to human Dopamine transporter in clonal cells2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
GBR compounds and mepyramines as cocaine abuse therapeutics: chemometric studies on selectivity using grid independent descriptors (GRIND).
AID200767Inhibition of [125I]RTI-55 binding to human SERT in clonal cells2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
GBR compounds and mepyramines as cocaine abuse therapeutics: chemometric studies on selectivity using grid independent descriptors (GRIND).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (44.44)18.7374
1990's4 (44.44)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]